News

ILoF (Intelligent Lab on Fiber) has today [15 July] received $1 million from Microsoft’s venture fund M12, Mayfield, and Melinda Gates’s Pivotal Ventures.

ILoF are one of four teams chosen from female-led companies from around the world to receive a share of $6m investment, resources and mentoring through the Female Founders Program.

Paiva’s session will focus on some of the pains behind drug development for heterogeneous diseases, and how they can be tackled using a #cloudbased library of disease #biomarkers and biological profiles.

iLoF will be one of ten startups to appear.

iLoF featured in The Daily Dealflow which delivers one vetted startup to your inbox every workday.

iLoF advances to other areas beyond Alzheimers and distinguishes and detects cancer cells, which is central to determining the optimal treatment.

iLoF CEO Luis Valente talks to Tech Talk about the difficulty in finding a cure for Alzheimer’s, and why with an aging population it is key to try and find treatments and cures for individuals with increasingly complex medical profiles.

iLoF chosen by Fundacion “la Caixa”and Banco BPI as a finalist for the Entrepreneur XXI Awards.

iLoF enables the stratification of tens of thousands of patients daily.

iLoF discusses how they want to accelerate personalized medicine.

Ferramenta é “baseada em medicina personalizada, rápida e de baixo custo” e poderá ser utilizada para prever a evolução da infeção por Covid-19 nos pacientes, segundo a Faculdade de Medicina do Porto.

iLoF joins the new Google for Startups UK program.

iLoF participates in the Mayor of London’s Techinvest.

iLoF named a finalist in Microsoft’s Female Founders Competition.

iLoF study demonstrates how their smart device can aid in the identification of cancer cells.

iLoF Co-founders are named in Forbes 30 Under 30 for Science & Healthcare.

iLoF named a Deep Tech Pioneer.

iLoF named one of 50 Gamechangers around Oxford and Thames Valley.

iLoF Co-founder and CTO Joana Paiva speaks about enabling a new generation of personalized treatments.

iLoF selected as one of the 10 most incredible startups and given the opportunity to present their vision at London’s Biohacking Congress.

iLoF Co-founder and COO Mehak Mumtaz appeared before Rising WISE discussing our EIT Health Wildcard Journey.

Co-founder and CTO Joana Paiva discusses how we are using optical fibers and artificial intelligence to enable personalized treatments.

iLoF is selected to participate in the Lev8 program at Oxford Foundry, Oxford University’s startup incubator.

In Riga, iLoF awarded 10,000 euros at EIT’s Jumpstarter 2019 for winning the Health category. At the same time, it was selected by Rockstart as a “Future Unicorn” at the Digital Freedom Fest.

Uma ‘startup’ do Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência (INESC TEC) recebeu dois milhões de euros de um programa de aceleração para, através da inteligência artificial e da fotónica, combater o Alzheimer.

Criar uma maior proximidade entre a academia, as startup e o tecido empresarial é o objectivo do prémio Altice International Innovation Award, que vai na 3ª edição.

Watch iLoF CEO Luis outline what sparked the creation of iLoF.

Madalena, João, Lourenço, Rui, David e Luís. Este foram os geeks caçados pelo Observador na quarta edição da Web Summit. Todos têm um pitch cativante e todos prometem revolucionar vários mercados.

iLoF presents our solution to a high-level audience of officials, investors, and industry experts.

iLoF wins Future Unicorn Pitch Competition.

Uma startup do Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência (INESC TEC) recebeu dois milhões de euros de um programa de aceleração para, através da inteligência artificial e da fotónica, combater o Alzheimer, foi anunciado esta quarta-feira, 6 de Novembro.

Através da inteligência artificial e da fotónica, o “sistema portátil” serve de arquivo a “impressões digitais” e permite “testes rápidos e pouco invasivos.

iLoF wins the Wild Card accelerator program and received 2 million euros of investment from EIT Health